Ladies check your birth control pills. Pfizer Inc. announced today that it has voluntarily recalled 14 lots of Lo/Ovral®-28 (norgestrel and ethinyl estradiol)Tablets and 14 lots of Norgestrel and Ethinyl Estradiol Tablets (generic)for customers in the U.S. market. An investigation by Pfizer found that some blister packs may contain an inexact count of inert or active ingredient tablets and that the tablets may be out of sequence.
As a result of this packaging error, the daily regimen for these oral contraceptives may be incorrect and could leave women without adequate contraception, and at risk for unintended pregnancy. These packaging defects do not pose any immediate health risks. However, consumers exposed to affected packaging should begin using a non-hormonal form of contraception immediately. Patients who have the affected product (lot number are provided below) should notify their physician and return the product to the pharmacy.
These products are packaged in blister packs containing 21 tablets of active ingredients and seven tablets of inert ingredients. Correct dosing of this product is important in avoiding the associated risks of an unplanned pregnancy.
Any adverse events that may be related to the use of these products should be reported to Akrimax Medical Information at 1- 877-509-3935 (8 AM to 7 PM Mon-Fri CST) or to FDA’s Med Watch Program either online, by regular mail or by fax.
- Johnson & Johnson Recalls Aveeno Baby Calming Comfort Lotion
- Britax Announces Voluntary Safety Recall of the Chaperone Infant Car Seat
- Bumbleride Offers Wheel Retrofit Kit For Indie & Indie Twin
- President’s Choice Recalls Organic Baby Powdered Cereal; May Be Rancid
SOURCE: Pfizer Press Release